- Home
- Publications
- Publication Search
- Publication Details
Title
Therapeutic modulators of STAT signalling for human diseases
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 12, Issue 8, Pages 611-629
Publisher
Springer Nature
Online
2013-08-01
DOI
10.1038/nrd4088
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Chemical Biology Approach to Developing STAT Inhibitors: Molecular Strategies for Accelerating Clinical Translation
- (2015) Erik A. Nelson et al. Oncotarget
- Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening
- (2013) Mingming Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
- (2013) Mi-Jung Kim et al. CANCER LETTERS
- A Novel Inhibitor of STAT3 Homodimerization Selectively Suppresses STAT3 Activity and Malignant Transformation
- (2013) X. Zhang et al. CANCER RESEARCH
- Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance
- (2013) A. Quintas-Cardama et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of NSCLC
- (2013) A.G. Pallis et al. LUNG CANCER
- JAKs and STATs in Immunity, Immunodeficiency, and Cancer
- (2013) John J. O'Shea et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brevilin A, a Novel Natural Product, Inhibits Janus Kinase Activity and Blocks STAT3 Signaling in Cancer Cells
- (2013) Xing Chen et al. PLoS One
- Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells
- (2012) Hee Jung Um et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibody
- (2012) Kuen-Feng Chen et al. BRITISH JOURNAL OF PHARMACOLOGY
- HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells
- (2012) Brent J. Tierney et al. CANCER BIOLOGY & THERAPY
- Sorafenib inhibits endogenous and IL-6/S1P induced JAK2-STAT3 signaling in human neuroblastoma, associated with growth suppression and apoptosis
- (2012) Fan Yang et al. CANCER BIOLOGY & THERAPY
- Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells
- (2012) Jie Yang et al. CANCER LETTERS
- Celastrol Suppresses Growth and Induces Apoptosis of Human Hepatocellular Carcinoma through the Modulation of STAT3/JAK2 Signaling Cascade In Vitro and In Vivo
- (2012) P. Rajendran et al. Cancer Prevention Research
- The Synthetic Triterpenoid CDDO-Methyl Ester Delays Estrogen Receptor-Negative Mammary Carcinogenesis in Polyoma Middle T Mice
- (2012) K. Tran et al. Cancer Prevention Research
- Inhibition of phosphorylated STAT3 by cucurbitacin I enhances chemoradiosensitivity in medulloblastoma-derived cancer stem cells
- (2012) Charn-Jung Chang et al. CHILDS NERVOUS SYSTEM
- Targeting Stat3 Abrogates EGFR Inhibitor Resistance in Cancer
- (2012) M. Sen et al. CLINICAL CANCER RESEARCH
- Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity
- (2012) Kuen-Feng Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Protective Effect of Caffeic Acid on Paclitaxel Induced Anti-Proliferation and Apoptosis of Lung Cancer Cells Involves NF-κB Pathway
- (2012) Chien-Liang Lin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
- (2012) Ke Sai et al. JOURNAL OF NEURO-ONCOLOGY
- A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line
- (2012) Inès Souissi et al. Molecular Cancer
- Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
- (2012) Sangkil Nam et al. Molecular Oncology
- Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling
- (2012) Sangkil Nam et al. Molecular Oncology
- Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells
- (2012) Sangkil Nam et al. Molecular Oncology
- SomaticSTAT3Mutations in Large Granular Lymphocytic Leukemia
- (2012) Hanna L.M. Koskela et al. NEW ENGLAND JOURNAL OF MEDICINE
- STAT3 Is Activated by JAK2 Independent of Key Oncogenic Driver Mutations in Non-Small Cell Lung Carcinoma
- (2012) Brendan D. Looyenga et al. PLoS One
- Curcumin Blocks Small Cell Lung Cancer Cells Migration, Invasion, Angiogenesis, Cell Cycle and Neoplasia through Janus Kinase-STAT3 Signalling Pathway
- (2012) Cheng-Liang Yang et al. PLoS One
- Anti-Angiogenic Activity of a Small Molecule STAT3 Inhibitor LLL12
- (2012) Hemant K. Bid et al. PLoS One
- Structurally Modified Curcumin Analogs Inhibit STAT3 Phosphorylation and Promote Apoptosis of Human Renal Cell Carcinoma and Melanoma Cell Lines
- (2012) Matthew A. Bill et al. PLoS One
- Selective Small Molecule Stat3 Inhibitor Reduces Breast Cancer Tumor-Initiating Cells and Improves Recurrence Free Survival in a Human-Xenograft Model
- (2012) Bhuvanesh Dave et al. PLoS One
- Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice
- (2012) Shing Hwa Liu et al. PLoS One
- Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
- (2012) X. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of a novelSTAT3mutation in a patient with hyper-IgE syndrome
- (2012) Trine H. Mogensen et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
- First-in-Human Trial of a STAT3 Decoy Oligonucleotide in Head and Neck Tumors: Implications for Cancer Therapy
- (2012) Malabika Sen et al. Cancer Discovery
- Chemosensitization of tumors by resveratrol
- (2011) Subash C. Gupta et al. Annals of the New York Academy of Sciences
- STAT6 phosphorylation inhibitors block eotaxin-3 secretion in bronchial epithelial cells
- (2011) Li Zhou et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors
- (2011) E. A. Nelson et al. BLOOD
- The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
- (2011) Stacey L Fossey et al. BMC CANCER
- Inhibitory effects of the JAK inhibitor CP690,550 on human CD4+ T lymphocyte cytokine production
- (2011) Kiyoshi Migita et al. BMC IMMUNOLOGY
- Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells
- (2011) Radhamani Kannaiyan et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cucurbitacin I inhibits tumorigenic ability and enhances radiochemosensitivity in nonsmall cell lung cancer-derived CD133-positive cells
- (2011) Han-Shui Hsu et al. CANCER
- HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition
- (2011) Karuppaiyah Selvendiran et al. CANCER BIOLOGY & THERAPY
- Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
- (2011) S. P. Tu et al. Cancer Prevention Research
- Bone Marrow Stroma-Secreted Cytokines Protect JAK2V617F-Mutated Cells from the Effects of a JAK2 Inhibitor
- (2011) T. Manshouri et al. CANCER RESEARCH
- Antiangiogenic and Antimetastatic Activity of JAK Inhibitor AZD1480
- (2011) H. Xin et al. CANCER RESEARCH
- Resveratrol Potentiates the Cytotoxic Oxidative Stress Induced by Chemotherapy in Human Colon Cancer Cells
- (2011) Francisca M. Santandreu et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer
- (2011) Cristina Grávalos et al. Clinical & Translational Oncology
- Effective treatment of experimental ragweed-induced asthma with STAT-6-IP, a topically delivered cell-penetrating peptide
- (2011) Y. Wang et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Immunomodulatory effect of water extract of cinnamon on anti-CD3-induced cytokine responses and p38, JNK, ERK1/2, and STAT4 activation
- (2011) Beom-Joon Lee et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Indirubin inhibits tumor growth by antitumor angiogenesis via blocking VEGFR2-mediated JAK/STAT3 signaling in endothelial cell
- (2011) Xiaoli Zhang et al. INTERNATIONAL JOURNAL OF CANCER
- Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice
- (2011) Grace-Ifeyinwa Onimoe et al. INVESTIGATIONAL NEW DRUGS
- Resveratrol suppresses tumorigenicity and enhances radiosensitivity in primary glioblastoma tumor initiating cells by inhibiting the STAT3 axis
- (2011) Yi-Ping Yang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
- (2011) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Gain-of-function humanSTAT1mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis
- (2011) Luyan Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- BCR-ABL1-independent PI3Kinase activation causing imatinib-resistance
- (2011) Hilmar Quentmeier et al. Journal of Hematology & Oncology
- Signal transducer and activator of transcription 3 is a major kinase-independent target of sorafenib in hepatocellular carcinoma
- (2011) Wei-Tien Tai et al. JOURNAL OF HEPATOLOGY
- STAT6 Expression in Multiple Cell Types Mediates the Cooperative Development of Allergic Airway Disease
- (2011) S. P. Chapoval et al. JOURNAL OF IMMUNOLOGY
- Potent and Selective Phosphopeptide Mimetic Prodrugs Targeted to the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 3
- (2011) Pijus K. Mandal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice
- (2011) Muthu K. Shanmugam et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-XL expression
- (2011) Gamal Badr et al. Lipids in Health and Disease
- JAK1 Activates STAT3 Activity in Non-Small-Cell Lung Cancer Cells and IL-6 Neutralizing Antibodies Can Suppress JAK1-STAT3 Signaling
- (2011) L. Song et al. MOLECULAR CANCER THERAPEUTICS
- Therapeutic Potential of AZD1480 for the Treatment of Human Glioblastoma
- (2011) B. C. McFarland et al. MOLECULAR CANCER THERAPEUTICS
- Biological activity of piceatannol: Leaving the shadow of resveratrol
- (2011) Hanna Piotrowska et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- STAT1Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis
- (2011) Frank L. van de Veerdonk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion
- (2011) Meng Sun et al. PROSTATE
- The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
- (2011) E Derenzini et al. Blood Cancer Journal
- A novel small-molecule disrupts Stat3 SH2 domain–phosphotyrosine interactions and Stat3-dependent tumor processes
- (2010) Xiaolei Zhang et al. BIOCHEMICAL PHARMACOLOGY
- Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis?
- (2010) Amy E. Lovett-Racke et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- First report of phase 2 study of dasatinib with hyper-CVAD for the frontline treatment of patients with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia
- (2010) F. Ravandi et al. BLOOD
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway
- (2010) Keinosuke Ryu et al. BMC CANCER
- Thymoquinone inhibits proliferation, induces apoptosis and chemosensitizes human multiple myeloma cells through suppression of signal transducer and activator of transcription 3 activation pathway
- (2010) Feng Li et al. BRITISH JOURNAL OF PHARMACOLOGY
- γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent
- (2010) Peramaiyan Rajendran et al. BRITISH JOURNAL OF PHARMACOLOGY
- Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
- (2010) Feng Li et al. CANCER LETTERS
- Inhibition of EGFR-STAT3 Signaling with Erlotinib Prevents Carcinogenesis in a Chemically-Induced Mouse Model of Oral Squamous Cell Carcinoma
- (2010) R. J. Leeman-Neill et al. Cancer Prevention Research
- STAT2 Contributes to Promotion of Colorectal and Skin Carcinogenesis
- (2010) A. M. Gamero et al. Cancer Prevention Research
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells
- (2010) J. Lee et al. CARCINOGENESIS
- Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway
- (2010) Y. Dong et al. CARCINOGENESIS
- Inhibition of p-STAT3 Enhances IFN- Efficacy against Metastatic Melanoma in a Murine Model
- (2010) L. Y. Kong et al. CLINICAL CANCER RESEARCH
- Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
- (2010) R. J. Leeman-Neill et al. CLINICAL CANCER RESEARCH
- Targeted Blockage of Signal Transducer and Activator of Transcription 5 Signaling Pathway with Decoy Oligodeoxynucleotides Suppresses Leukemic K562 Cell Growth
- (2010) Xiaozhong Wang et al. DNA AND CELL BIOLOGY
- Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin
- (2010) Tingyan Liu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Preclinical characterization of atiprimod, a novel JAK2 AND JAK3 inhibitor
- (2010) Alfonso Quintás-Cardama et al. INVESTIGATIONAL NEW DRUGS
- A Cell-permeable Stat3 SH2 Domain Mimetic Inhibits Stat3 Activation and Induces Antitumor Cell Effectsin Vitro
- (2010) Wei Zhao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- γ-Tocotrienol but Not γ-Tocopherol Blocks STAT3 Cell Signaling Pathway through Induction of Protein-tyrosine Phosphatase SHP-1 and Sensitizes Tumor Cells to Chemotherapeutic Agents
- (2010) Ramaswamy Kannappan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- IL-4 Regulates Skin Homeostasis and the Predisposition toward Allergic Skin Inflammation
- (2010) S. Sehra et al. JOURNAL OF IMMUNOLOGY
- Targeting transcription factor Stat4 uncovers a role for interleukin-18 in the pathogenesis of severe lupus nephritis in mice
- (2010) Julia Menke et al. KIDNEY INTERNATIONAL
- The gold compound auranofin induces apoptosis of human multiple myeloma cells through both down-regulation of STAT3 and inhibition of NF-κB activity
- (2010) Aya Nakaya et al. LEUKEMIA RESEARCH
- A novel small molecule inhibits STAT3 phosphorylation and DNA binding activity and exhibits potent growth suppressive activity in human cancer cells
- (2010) Li Lin et al. Molecular Cancer
- Sorafenib Induces Growth Arrest and Apoptosis of Human Glioblastoma Cells through the Dephosphorylation of Signal Transducers and Activators of Transcription 3
- (2010) Fan Yang et al. MOLECULAR CANCER THERAPEUTICS
- Microtubule-Targeted Chemotherapeutic Agents Inhibit Signal Transducer and Activator of Transcription 3 (STAT3) Signaling
- (2010) S. R. Walker et al. MOLECULAR PHARMACOLOGY
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
- (2010) Jianyong Chen et al. ACS Medicinal Chemistry Letters
- Identification of a New Series of STAT3 Inhibitors by Virtual Screening
- (2010) Kenji Matsuno et al. ACS Medicinal Chemistry Letters
- A Novel STAT6 Inhibitor AS1517499 Ameliorates Antigen-Induced Bronchial Hypercontractility in Mice
- (2009) Yoshihiko Chiba et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Capsaicin inhibits the IL-6/STAT3 pathway by depleting intracellular gp130 pools through endoplasmic reticulum stress
- (2009) Hyun Kyoung Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potent and orally active STAT6 inhibitors
- (2009) Shinya Nagashima et al. BIOORGANIC & MEDICINAL CHEMISTRY
- LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model
- (2009) B Fuh et al. BRITISH JOURNAL OF CANCER
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
- (2009) Ja Eun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Evaluation of anti-leukemia effect of resveratrol by modulating SATA3 signaling
- (2009) Tan Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibitory effect of cucurbitacin E on pancreatic cancer cells growth via STAT3 signaling
- (2009) Chunyan Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Targeting Signal Transducer and Activator of Transcription Signaling Pathway in Leukemias
- (2009) Mustafa Benekli et al. JOURNAL OF CLINICAL ONCOLOGY
- Boswellic Acid Blocks Signal Transducers and Activators of Transcription 3 Signaling, Proliferation, and Survival of Multiple Myeloma via the Protein Tyrosine Phosphatase SHP-1
- (2009) Ajaikumar B. Kunnumakkara et al. MOLECULAR CANCER RESEARCH
- Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
- (2009) Xuejun Xu et al. PLoS One
- Interleukin-13 Augments Bronchial Smooth Muscle Contractility with an Up-Regulation of RhoA Protein
- (2008) Yoshihiko Chiba et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Regulation of apoptosis by resveratrol through JAK/STAT and mitochondria mediated pathway in human epidermoid carcinoma A431 cells
- (2008) Esha Madan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Identification of 4-benzylamino-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5-carboxamide derivatives as potent and orally bioavailable STAT6 inhibitors
- (2008) Shinya Nagashima et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of the catechol structural moiety as a Stat3 SH2 domain inhibitor by virtual screening
- (2008) Wenshan Hao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3
- (2008) E. A. Nelson et al. BLOOD
- CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells
- (2008) Zhenfeng Duan et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Lack of toxicity of a STAT3 decoy oligonucleotide
- (2008) Malabika Sen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cryptotanshinone Inhibits Constitutive Signal Transducer and Activator of Transcription 3 Function through Blocking the Dimerization in DU145 Prostate Cancer Cells
- (2008) D.-S. Shin et al. CANCER RESEARCH
- AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts
- (2008) T. H.W. Stadlbauer et al. CARDIOVASCULAR RESEARCH
- Discovery of Chromone-Based Inhibitors of the Transcription Factor STAT5
- (2008) Judith Müller et al. CHEMBIOCHEM
- PRAVASTATIN ATTENUATES INTERFERON-γ ACTION VIA MODULATION OF STAT1 TO PREVENT AORTIC ATHEROSCLEROSIS IN APOLIPOPROTEIN E-KNOCKOUT MICE
- (2008) Xiao-Xu Zhou et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Interleukin-4, Interleukin-13, Signal Transducer and Activator of Transcription Factor 6, and Allergic Asthma
- (2008) Douglas Kuperman et al. CURRENT MOLECULAR MEDICINE
- Targeting STAT3 in cancer: how successful are we?
- (2008) Peibin Yue et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Avicin D Selectively Induces Apoptosis and Downregulates p-STAT-3, bcl-2, and Survivin in Cutaneous T-Cell Lymphoma Cells
- (2008) Chunlei Zhang et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Resveratrol addiction: To die or not to die
- (2008) Mehdi Shakibaei et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search